¡¡
¡¡
¡¡
HOME > ÇÐȸ°£Ç๰ > ¿ë¾î»çÀü
Á¦¸ñ A Case of Dapsone Induced Hemolytic Anemia
ÀúÀÚ Seong Min Park, Tae Kyung Lee, Doo Chan Moon, Kyung Sool Kwon, Tae Ahn Chung ¼Ò¼Ó Dept. of Dermatology, College of Medicine, Pusan National University, Pusan, Korea
³âµµ 1988 ±Ç 21
È£ 1 ¹øÈ£
½ÃÀÛÆäÀÌÁö 51 ³¡ÆäÀÌÁö 54
÷ºÎ
¿ä¾à Dapsone (4,4'diaminodiphenylsulfone, DDS), which is a widely used antileprotic drug,
is a oxidant drug with a hematologic toxicity, such as hemolysis, methemoglobinemia,
and hemolytic anemia.
We presented a case of dapsone induced hemolytic anemia developed in a 42-year-old
female during antileprotic treatment containing dapsone, clofazimine, and rifampin.
After the discontinuation of dapsone, the laboratory anemic findings were returned to
normal.
³»¿ë
 
¡¡
¡¡
¡¡